Oculis Holding AG (OCS)

9.70 +0.08 (+0.83%) At close: 04:00PM EST

Oculis Holding AG

Bahnhofstrasse 7
Zug 6300
Switzerland
41 58 810 0182
https://oculis.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 28

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Riad Sherif M.B.A., M.D.	CEO & Director	N/A	N/A	1968
Ms. Sylvia Cheung	Chief Financial Officer	N/A	N/A	1975
Mr. Weibo Ding	Global COO & GM of China	N/A	N/A	1971
Dr. Bastian Dehmel	Chief Development Officer & Head of Development	N/A	N/A	1971
Dr. Joanne Chang M.D., Ph.D.	Head of Medical Affairs & Chief Medical Officer	N/A	N/A	1961
Mr. Páll Ragnar Jóhannesson	Chief Strategy Officer	N/A	N/A	1981
Dr. Fang Li	Senior Vice President of Regulatory Affairs	N/A	N/A	N/A
Ms. Rebecca Weil	Chief Commercial Officer	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company's lead candidate is OCS-01, a topical dexamethasone formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for keratoconjunctivitis sicca, or dry eye disease; and OCS-05, a novel neuroprotective agent for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.

Corporate governance

Oculis Holding AG’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.